Why Artisan Mid Cap Trimmed Health Care
Artisan Mid Cap manager Andy Stephens explains why the fund's weighting in health care has gone down recently.
Greg Carlson: One other area I wanted to touch on is a health care. This is Artisan Mid Cap Fund in particular I think has been a fund that's concentrated more on growth companies that have more stable revenue streams. Health care was a source of those companies in the past, and yet more recently the fund's weighting has gone down. Can you talk a little bit about what that's reflecting?
Andrew Stephens: A lot of it is reflecting better opportunities in other parts of the economy and other parts of the portfolio. Health care, by its nature, is less cyclical. You get longer-trending profit cycles in health care, and they tend to be less directly affected by the economy. So in the downturn, in the credit crisis, a lot of our health-care companies did their job. They held up. The earning streams were relatively stable, and they actually, in our minds, got a little overvalued.
Greg Carlson does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.